51 Grants (Page 1 of 3)
2018
IU training Program in Molecular Physiology and Clinical Mechanisms of Lung Disease
DAVIS, STEPHANIE D and Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL091816-09), $263,128USD, 03/01/2008 -- 01/31/2020
2017
Pulmonary Hypertension Breakthrough Initiative
Erzurum, Serpil C⋅Geraci, Mark W⋅GRIZZLE, WILLIAM E⋅MCLAUGHLIN, VALLERIE and Rabinovitch, Marlene
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R24HL123767-05), $2,507,257USD, 10/30/2015 -- 06/30/2018
2016
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 4P30CA046934-28-8134), $131,860USD, 2016
 
Pulmonary Hypertension Breakthrough Initiative
Erzurum, Serpil C⋅Geraci, Mark W⋅GRIZZLE, WILLIAM E⋅MCLAUGHLIN, VALLERIE and Rabinovitch, Marlene
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R24HL123767-04), $2,518,872USD, 10/30/2015 -- 06/30/2018
2015
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA046934-27), $130,991USD, 2015
 
Multidisciplinary Research Training in Respiratory Disease
Geraci, Mark W and Schwarz, Marvin I
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2T32HL007085-41), $804,210USD, 07/01/1975 -- 06/30/2020
 
Pulmonary Hypertension Breakthrough Initiative
Erzurum, Serpil C⋅Geraci, Mark W⋅GRIZZLE, WILLIAM E⋅MCLAUGHLIN, VALLERIE and Rabinovitch, Marlene
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 7R24HL123767-03), $564,952USD, 10/30/2015 -- 06/30/2018
 
Pulmonary Hypertension Breakthrough Initiative
Erzurum, Serpil C⋅Geraci, Mark W⋅GRIZZLE, WILLIAM E⋅MCLAUGHLIN, VALLERIE and Rabinovitch, Marlene
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R24HL123767-02), $1,969,871USD, 09/15/2014 -- 08/23/2015
2014
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
Tuder, Rubin M and Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA164780-04), $580,374USD, 08/15/2011 -- 05/31/2015
 
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA046934-26), $127,977USD, 2014
 
Multidisciplinary Research Training in Respiratory Disease
Geraci, Mark W and Schwarz, Marvin I
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007085-40), $500,863USD, 07/01/1975 -- 06/30/2015
 
Pulmonary Hypertension Breakthrough Initiative
Erzurum, Serpil C⋅Geraci, Mark W⋅GRIZZLE, WILLIAM E⋅MCLAUGHLIN, VALLERIE and Rabinovitch, Marlene
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R24HL123767-01), $2,557,971USD, 09/15/2014 -- 06/30/2018
2013
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
Geraci, Mark W and Tuder, Rubin M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA164780-03), $564,154USD, 08/15/2011 -- 05/31/2015
 
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3P30CA046934-25S2), $961USD, 2013
 
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA046934-25), $129,189USD, 2013
 
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL014985-40), $300,464USD, 2013
 
Multidisciplinary Research Training in Respiratory Disease
Geraci, Mark W and Schwarz, Marvin I
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007085-39), $846,271USD, 07/01/1975 -- 06/30/2015
2012
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K12HL090147-05), $399,600USD, 09/27/2007 -- 01/31/2014
 
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
Geraci, Mark W and Tuder, Rubin M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA164780-02), $601,421USD, 08/15/2011 -- 05/31/2015
 
GENE EXPRESSION CORE
Geraci, Mark W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2P30CA046934-24-8134), $132,147USD, 08/06/1997 -- 01/31/2017
 
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL014985-39-5100), $346,802USD, 2012
2011
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
Geraci, Mark W and Tuder, Rubin M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA164780-01), $602,705USD, 08/15/2011 -- 05/31/2015
 
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL014985-38), $314,170USD, 2011
2010
53rd Annual Thomas L Petty Aspen Lung Conference: Systems Biology of Lung Disease
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R13HL104796-01), $15,000USD, 07/01/2010 -- 06/30/2011
 
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases
Geraci, Mark W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K12HL090147-04), $399,600USD, 09/27/2007 -- 07/31/2013